Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK
- PMID: 25079680
- DOI: 10.1111/bju.12865
Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK
Abstract
Objective: To determine the efficacy of fluoroquinolone prophylaxis in patients undergoing transrectal ultrasonography (TRUS)-guided biopsy of the prostate in the Norwich population, and its correlation with ciprofloxacin resistance in the faecal flora. We also aimed to determine the usefulness of a pre-biopsy rectal screen for resistant bacteria in these patients.
Patients and methods: The incidence and microbiology of sepsis after TRUS-guided prostate biopsies between 2007 and 2011 was audited retrospectively. Subsequently, in 2012, a prospective study was performed, collecting the same data but also culturing rectal swabs from all patients undergoing TRUS-guided biopsy, with a post-biopsy follow-up period of 6 months. All patients were given prophylactic oral ciprofloxacin, as per Trust policy (750 mg 1 h before biopsy, followed by 250 mg twice daily for 3 subsequent days).
Results: Between 2007 and 2011, 3600 patients underwent TRUS-guided biopsy. Among these, 11 (0.3%) were admitted to hospital for post-biopsy related sepsis but only 4 (0.1%) had ciprofloxacin-resistant Escherichia coli confirmed from blood cultures: three had ciprofloxacin-susceptible Enterobacteriaceae, and four had no ciprofloxacin susceptibility data. In 2012, 10 (3.7%) of 267 patients sampled before biopsy had ciprofloxacin-resistant E. coli recovered on rectal swab culture but none of these men presented with post-biopsy sepsis; during the 6-month follow-up period, seven patients were diagnosed with urinary tract infections.
Conclusion: Ciprofloxacin-resistant Enterobacteriaceae remains rare in the intestinal flora of the Norwich TRUS population, meaning that the drug remains adequate as prophylaxis. Pre-biopsy rectal swabs may be useful for individual departments to periodically assess their own populations and to ensure their antibiotic policy remains valid. In populations where resistance is known to be highly prevalent, pre-biopsy rectal swabs can help guide addition of further antibiotics to prevent post-biopsy septicaemia.
Keywords: fluoroquinolone; infection; prostate biopsy; rectal swabs; sepsis.
© 2014 The Authors BJU International © 2014 BJU International Published by John Wiley & Sons Ltd.
Similar articles
-
Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital.BJU Int. 2019 May;123 Suppl 5:43-46. doi: 10.1111/bju.14745. Epub 2019 Apr 23. BJU Int. 2019. PMID: 31012990
-
Infection after transrectal ultrasound-guided prostate biopsy.Korean J Urol. 2015 May;56(5):346-50. doi: 10.4111/kju.2015.56.5.346. Epub 2015 Apr 6. Korean J Urol. 2015. PMID: 25964834 Free PMC article. Review.
-
Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.J Urol. 2015 Aug;194(2):397-402. doi: 10.1016/j.juro.2015.03.110. Epub 2015 Apr 3. J Urol. 2015. PMID: 25846415
-
Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli.Clin Infect Dis. 2013 Jul;57(2):267-74. doi: 10.1093/cid/cit193. Epub 2013 Mar 26. Clin Infect Dis. 2013. PMID: 23532481 Review.
-
Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.BJU Int. 2013 May;111(6):946-53. doi: 10.1111/j.1464-410X.2012.11637.x. Epub 2013 Mar 6. BJU Int. 2013. PMID: 23464844 Clinical Trial.
Cited by
-
Uropathogenic Escherichia coli population structure and antimicrobial susceptibility in Norfolk, UK.J Antimicrob Chemother. 2023 Aug 2;78(8):2028-2036. doi: 10.1093/jac/dkad201. J Antimicrob Chemother. 2023. PMID: 37358190 Free PMC article.
-
A New Nomogram Allowing Physicians to Predict Patients at High Risk of Fever Occurring After Prostate Biopsy.Med Sci Monit. 2020 Mar 22;26:e921350. doi: 10.12659/MSM.921350. Med Sci Monit. 2020. PMID: 32200388 Free PMC article.
-
Antimicrobial lubricant reduces rectal bacteria at transrectal prostate biopsy: results from a prospective randomized trial.World J Urol. 2018 Jun;36(6):871-876. doi: 10.1007/s00345-018-2221-y. Epub 2018 Feb 7. World J Urol. 2018. PMID: 29417288 Clinical Trial.
-
Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.PLoS One. 2017 Jan 25;12(1):e0170319. doi: 10.1371/journal.pone.0170319. eCollection 2017. PLoS One. 2017. PMID: 28122053 Free PMC article.
-
Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis.Prostate Cancer Prostatic Dis. 2016 Dec;19(4):417-422. doi: 10.1038/pcan.2016.36. Epub 2016 Aug 16. Prostate Cancer Prostatic Dis. 2016. PMID: 27526964
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical